Subscribe
Numerous randomized trials have evaluated antihypertensive regimens in various settings, including those complicated by at least one other vascular disorder. Among these trials are the Modification of Diet in Renal Disease (MDRD) Study in hypertensive patients with kidney disease; the Comparison of AMlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) Study and the INternational VErapamil-trandolapril STudy (INVEST) in patients with hypertension and coronary disease; and the Perindopril pROtection aGainst REcurrence of Stroke Study (PROGRESS) in hypertensive patients who have had a stroke.
A Stand-Up Approach to Diagnosing Orthostatic Hypotension
Renal Artery Stenosis: When to Order Diagnostic Tests-When to Intervene?
Non-ST-Segment Elevation MI and Unstable Angina: What Role for Anticoagulants and Antiplatelet Agents?
Diabetic Foot Problems: Keys to Effective, Aggressive Prevention
Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH
June 15, 2026
Marla D. Lipsyc-Sharf, MD; Richard Zelkowitz, MD
June 17-19, 2026
Seth A. Wander, MD, PhD; Kate Baxstrom, MD
Richard Bedlack, MD, PhD
June 23, 2026
1 Session is Available!
Terry Heiman-Patterson, MD
Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA
Selina R. McGee, OD, FAAO
Arjan Hura, MD; Neda Shamie, MD; Kristin Barnes, OD
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; John Hovanesian, MD, FACS
Seth A. Wander, MD, PhD; Yang Liu, MD
Yelda Nouri, MD; Sara Nunnery, MD, MSCI
July 10-11, 2026
Rachel N. Grisham, MD; Ramez N. Eskander, MD; Oladapo Yeku, MD, PhD